MHA 707 EXAM B LATEST 2026 UPDATED QUESTIONS
AND VERIFIED 100% SOLUTIONS (2026/2027) GRADE:
A+|STATUS: GUARANTEED PASS
Biologics - Answers -a product that is produced from living organisms or contains components
of living organisms
Biological Products - Answers -regulated by the Food and Drugs. Administration (FDA) are used
to diagnose, prevent, treat, and cure diseases and medical conditions
FDA (Food and Drug Administration) - Answers -Products intended to cure, treat, mitigate,
diagnose, or prevent disease in humans or otherwise affect the structure or function of the
human body through chemical action in and/or metabolized by the human body are considered
human drugs or biological products.
Biological Products - Answers -complex mixtures of "big molecule drugs" produced through
biotechnology in a living system, such as a microorganism, plant cell, or animal cell are not
easily identified or characterized.
Biologics Characteristics - Answers -•Due to their complex nature, it is challenging to ensure the
product remains consistent, and so the production process becomes critical ("the product is the
process")
•considered a "specialty" drug
•In 2018, biologic market est. at $125 B (up 50% from 2014)
1|Page
,•represent the cutting edge of biomedical research
17% of all drug approvals
•is 3 of the top selling medicines in 2017
What are the two classes of FDA drugs? - Answers -Conventional" or "small molecule" drugs
typically contain an active pharmaceutical ingredient
Speciality Drug Criteria - Answers -•Available in very limited supply
•Require special handling (e.g., constant temperature regulation or biohazard or similar toxicity)
•Have a very high price tag
•Includes Orphan Drugs and Biologics
• 4 of the top 5 med were specialty, net spending is 46.5%
GRASE (general recognized as safe and effective) Criteria - Answers -which requires published
research
supporting safe unsupervised use of the product
OTC drugs
DEA Drug Schedules - Answers -•Schedule I: no accepted medical use and a high potential for
abuse and therefore may not be prescribed or dispensed
•Schedule II-V: varying controls on their manufacture, distribution, and sales
•Unscheduled: no DEA restrictions
•The FDA does not proactively control vitamins and supplements
2|Page
,Americans spent ~$34 B in 2019
New Drug Application (NDA) - Answers -process that includes animal testing, progressively
larger human trials, review of the drug's labeling, and an inspection of the facilities where the
drug would be manufactured
Rule of GRASE - Answers -Drugs must be made available OTC if consumers can use it safely and
effectively without professional guidance per package labelling
Cost and Speciality Drugs - Answers -4 of the top 5 medicines by nondiscounted spending were
specialty drugs and specialty share of net spending on drugs rose from 24.7% in 2008 to 46.5%
Orphan Disease - Answers -Diseases that occur in less than 200,000 people in the U.S.
Therefore, drugs for these diseases wouldn't be economically feasible to
develop unless subsidized
- Includes most "biologicals"
Orphan Drug Act of 1983 - Answers -grants special tax treatment and sometimes offers
federal grant money to fund research
Orphan drugs for cancer generate the largest profits
3|Page
, Development of new drugs - Answers -Patents could last up to 20 years from date of filing
It can cost millions to billions of dollars
Could take up to 15 years to be FDA approved
Phases/ Stages of Development of New Drugs 0-4 - Answers -Preclinical: human cell lines,
animals or targeted pathogen
Phase 0 - Pharmacokinetics studies (PK), sub-therapeutic doses, 10 subjects (how drug absorbed
in body with small doses)
Phase I - safety profile; 20-100 subjects; potential clinical efficacy (70% drug candidates make it
through Phase I)
Phase II - side effects; 100-300 subjects; clinical efficacy w/dosage ranges (about 1/3 of drug
candidates make it through Phase II)
Phase III - Larger trial to verify preliminary assumptions; 30 - thousand subjects; (about 25% of
drug candidates make it through Phase III)
Phase IV - post-marketing surveillance (individual incidents reported)
Operation Warp Speed - Answers -A public-private partnership was initiated to facilitate and
accelerate the development, manufacturing, and distribution of COVID-19 vaccines (10billion
dollars)
Phases 1-3 ran together
Critical Requirements for Attracting Investments for New Drugs - Answers -Intellectual property
(IP) protections (ex: patents) and market exclusivity are considered
4|Page
AND VERIFIED 100% SOLUTIONS (2026/2027) GRADE:
A+|STATUS: GUARANTEED PASS
Biologics - Answers -a product that is produced from living organisms or contains components
of living organisms
Biological Products - Answers -regulated by the Food and Drugs. Administration (FDA) are used
to diagnose, prevent, treat, and cure diseases and medical conditions
FDA (Food and Drug Administration) - Answers -Products intended to cure, treat, mitigate,
diagnose, or prevent disease in humans or otherwise affect the structure or function of the
human body through chemical action in and/or metabolized by the human body are considered
human drugs or biological products.
Biological Products - Answers -complex mixtures of "big molecule drugs" produced through
biotechnology in a living system, such as a microorganism, plant cell, or animal cell are not
easily identified or characterized.
Biologics Characteristics - Answers -•Due to their complex nature, it is challenging to ensure the
product remains consistent, and so the production process becomes critical ("the product is the
process")
•considered a "specialty" drug
•In 2018, biologic market est. at $125 B (up 50% from 2014)
1|Page
,•represent the cutting edge of biomedical research
17% of all drug approvals
•is 3 of the top selling medicines in 2017
What are the two classes of FDA drugs? - Answers -Conventional" or "small molecule" drugs
typically contain an active pharmaceutical ingredient
Speciality Drug Criteria - Answers -•Available in very limited supply
•Require special handling (e.g., constant temperature regulation or biohazard or similar toxicity)
•Have a very high price tag
•Includes Orphan Drugs and Biologics
• 4 of the top 5 med were specialty, net spending is 46.5%
GRASE (general recognized as safe and effective) Criteria - Answers -which requires published
research
supporting safe unsupervised use of the product
OTC drugs
DEA Drug Schedules - Answers -•Schedule I: no accepted medical use and a high potential for
abuse and therefore may not be prescribed or dispensed
•Schedule II-V: varying controls on their manufacture, distribution, and sales
•Unscheduled: no DEA restrictions
•The FDA does not proactively control vitamins and supplements
2|Page
,Americans spent ~$34 B in 2019
New Drug Application (NDA) - Answers -process that includes animal testing, progressively
larger human trials, review of the drug's labeling, and an inspection of the facilities where the
drug would be manufactured
Rule of GRASE - Answers -Drugs must be made available OTC if consumers can use it safely and
effectively without professional guidance per package labelling
Cost and Speciality Drugs - Answers -4 of the top 5 medicines by nondiscounted spending were
specialty drugs and specialty share of net spending on drugs rose from 24.7% in 2008 to 46.5%
Orphan Disease - Answers -Diseases that occur in less than 200,000 people in the U.S.
Therefore, drugs for these diseases wouldn't be economically feasible to
develop unless subsidized
- Includes most "biologicals"
Orphan Drug Act of 1983 - Answers -grants special tax treatment and sometimes offers
federal grant money to fund research
Orphan drugs for cancer generate the largest profits
3|Page
, Development of new drugs - Answers -Patents could last up to 20 years from date of filing
It can cost millions to billions of dollars
Could take up to 15 years to be FDA approved
Phases/ Stages of Development of New Drugs 0-4 - Answers -Preclinical: human cell lines,
animals or targeted pathogen
Phase 0 - Pharmacokinetics studies (PK), sub-therapeutic doses, 10 subjects (how drug absorbed
in body with small doses)
Phase I - safety profile; 20-100 subjects; potential clinical efficacy (70% drug candidates make it
through Phase I)
Phase II - side effects; 100-300 subjects; clinical efficacy w/dosage ranges (about 1/3 of drug
candidates make it through Phase II)
Phase III - Larger trial to verify preliminary assumptions; 30 - thousand subjects; (about 25% of
drug candidates make it through Phase III)
Phase IV - post-marketing surveillance (individual incidents reported)
Operation Warp Speed - Answers -A public-private partnership was initiated to facilitate and
accelerate the development, manufacturing, and distribution of COVID-19 vaccines (10billion
dollars)
Phases 1-3 ran together
Critical Requirements for Attracting Investments for New Drugs - Answers -Intellectual property
(IP) protections (ex: patents) and market exclusivity are considered
4|Page
